Buscador de publicaciones

Publicaciones

  • Roca-Grande J, Mir-Cros A, Munoz-Almagro C, Lung M, Bellés-Bellés A, Càmara J, Cercenado E, Galán-Ladero MÁ, Martín-Nalda A, Moreno-Mingorance A, Navarro de la Cruz D, Orellana MÁ, Palop B, Pérez-Argüello A, Puigsech-Boixeda G, Quesada MD, Rivera A, Rodriguez-Fernandez A, Ruiz de Gopegui E, Sarvisé C, Soler-García a, Viñado B, Larrosa N and González-López JJ.

    Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage

    EMERGING MICROBES & INFECTIONS . 14(1): 2482696-2482696. Nº de citas: 1

    [doi:10.1080/22221751.2025.2482696]

  • Lluansí A, Brotons-de los Reyes P, Díaz-Silva M, Rigalos A, García-Beltran C, Pérez-Argüello A, Cisneros M, Blanco-Fuertes M, Henares-Bonilla D, Ibañez-Toda L and Munoz-Almagro C.

    Early development and dynamics of nasopharyngeal microbiota in infants during the COVID-19 pandemic: a 2-year prospective birth cohort study

    Respiratory Research . 26(1): 240-240.

    [doi:10.1186/s12931-025-03307-5]

  • Cisneros M, Blanco-Fuertes M, Lluansí A, Brotons-de los Reyes P, Henares-Bonilla D, Pérez-Argüello A, González-Comino G, Ciruela Navas P, AUREA MIRA VALLET and Munoz-Almagro C.

    Synergistic inhibition of pneumococcal growth by Dolosigranulum pigrum and Corynebacterium pseudodiphtheriticum: insights into nasopharyngeal microbial interactions.

    Microbiology spectrum . 13(7): .

    [doi:10.1128/spectrum.00138-25]

  • Lara C, Orsini M, Pohlenz M, Ulloa K, Castro I, Munoz-Almagro C and Brotons-de los Reyes P.

    Impact of the COVID-19 national health alert on Enterobacterales hospital outbreaks in Chile

    JOURNAL OF HOSPITAL INFECTION . 161: 28-36.

    [doi:10.1016/j.jhin.2025.03.003]

  • Henares-Bonilla D, Cubero M, Irene Martínez de Albéniz, Arranz A, Rocafort-Junca M, Brotons-de los Reyes P, Pérez-Argüello A, Troyano MJ, Gene-Giralt A, Lluansí A, Iriondo-Sanz M, Jordán-García I, Fortuny-Guasch C, Urrea M and Munoz-Almagro C.

    Rapid identification of a Serratia marcescens outbreak in a neonatal intensive care unit by third-generation long-read nanopore sequencing.

    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL . 14(1): 63-63.

    [doi:10.1186/s13756-025-01582-x]

  • Fernández de Sevilla-Estrach M, Alcaraz-Soler C, Soldevila N, Izquierdo C, Esteva-Afonso C, Fernando Moraga Llop, González-Peris S, Ciruela Navas P, Álvaro Díaz Conradi, Pérez-Argüello A, Viñado B, Domínguez A, García-García JJ and Munoz-Almagro C.

    Clinical manifestations, serotype distribution, and incidence of pediatric invasive pneumococcal disease in Catalonia (Spain), 2018-2022

    EUROPEAN JOURNAL OF PEDIATRICS . 184(5): 323-323.

    [doi:10.1007/s00431-025-06137-1]

  • Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung CF, Tomlinson J, Stolyarov K, Shchomak Z, Poovorawan Y, Nokes DJ, Munoz-Almagro C, Mandelboim M, Keck JW, Langley JM, Heikkinen T, Deng J, Colson P, Chakhunashvili G, Caballero MT, Bont L, Feikin DR, Nair H, Wang X and Li Y.

    Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.

    NATURE COMMUNICATIONS . 16(1): 1610-1610. Nº de citas: 5

    [doi:10.1038/s41467-025-56776-z]

  • Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Zvirbulis V, Zavadska D, Szuldrzynski K, Gaio V, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Krievins D, Barzdina EA, Melo A, Kosa AG, Miron VD, Munoz-Almagro C, Milagro AM, Bacci S, Kramarz P and Nardone A.

    Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023)

    Vaccine . 45: 126615-126615.

    [doi:10.1016/j.vaccine.2024.126615]

  • Shaw D, Torreblanca RA, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Casanova C, Choi EH, Claus H, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Desmet S, Domenech M, Drew R, Plessis MD, Duarte C, Fuursted K, Golden A, Almeida SCG, Henares-Bonilla D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Jacobsson S, Johnson C, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, Ayala MEL, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Munoz-Almagro C, Murdoch D, Musilek M, Novakova L, Oftadeh S, Pérez-Argüello A, Pérez-Vázquez MD, Perrin M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sempere J, Siira L, de Lemos APS, Sintchenko V, Skoczynska A, Slotved HC, Smith AJ, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Moreno JV, Vohrnova S, von Gottberg A, Yuste J and Brueggemann AB.

    The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.

    LANCET DIGITAL HEALTH . : . Nº de citas: 2

    [doi:10.1016/S2589-7500(24)00241-3]

  • Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Munoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, Eugenia León M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacón G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL and Deloria Knoll M.

    Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.

    LANCET INFECTIOUS DISEASES . : . Nº de citas: 9

    [doi:10.1016/S1473-3099(24)00588-7]